News & Analysis on Clinical Trial Services & Contract Research And Development
Active pharmaceutical ingredient specialist Calyx Chemicals and Pharmaceuticals is planning an acquisition within the next two years, probably in the US or Europe, according to chief executive Smitesh Shah.
Germany-based Diapharm has launched a service allowing pharmaceutical manufacturers to perform joint third-party audits of active pharmaceutical ingredients (APIs).
EnWave says that its freezeREV dehydration technology can reduce the moisture content of single vial vaccines to between 3 and 3.5 per cent, bettering the mark achieved by its bioREV platform.
Merck & Co has added additional sales staff by signing an outsourcing agreement with inVentiv Health.
UK-based Reaxa and Switzerland’s RohnerChem have teamed up to develop the former’s EnCat catalyst technology for industrial applications in the API and drug manufacturing sector.
Massachusetts needs to do more to produce workers for its life sciences industry if it is to avoid a skills shortage in years to come, according to research.
Dutch chemicals giant DSM and France’s LibraGen are targeting the chemical and pharmaceutical industries with their new chiral amine production accord, which aims to develop a range of new catalytic enzymes.